Examining melanoma risk in patients treated with biologics for common inflammatory diseases

This study combined the results of seven studies and compared the risk of melanoma among 34,000 patients treated with biologics and 135,000 patients treated with conventional systemic therapy for rheumatoid arthritis, psoriasis or inflammatory bowel disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news